Skip to main content
Premium Trial:

Request an Annual Quote

Zymark Provides Platforms for Dutch Gene Discovery Collaboration

NEW YORK, Oct. 21-Dyadic International and the Netherlands Organization for Applied Scientific Research will use two Zymark workstations for their eukaryotic gene discovery research collaboration, Zymark said today.


Dyadic is developing an automated system for eukaryotic gene screening, and is working with TNO researchers as part of its efforts to commercialize this system.


The collaborators, based in Zeist, the Netherlands, are using a Zymark Allegro system to produce a library of eukaryotic clones, and a Staccato system to screen the library.


Financial details of this agreement were not revealed.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.